Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,483 | 13,916 | 17,195 | 25,199 | 85,783 |
| Marketable Securities | 131,864 | 7,182 | 42,194 | 72,641 | N/A |
| Receivables | N/A | N/A | N/A | N/A | 960 |
| Other current assets | 0 | 0 | 0 | 0 | 1,618 |
| TOTAL | $152,976 | $23,546 | $60,181 | $100,205 | $92,075 |
| Non-Current Assets | |||||
| PPE Net | 385 | 973 | 1,614 | 2,393 | 4,068 |
| Other Non-Current Assets | 2,518 | 3,753 | 4,517 | 5,133 | 6,153 |
| TOTAL | $2,903 | $4,726 | $6,131 | $7,526 | $10,220 |
| Total Assets | $155,879 | $28,272 | $66,312 | $107,730 | $102,295 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 16,209 | 3,149 | 3,861 | 710 |
| Accounts payable and accrued liabilities | 4,786 | 3,179 | 2,174 | 1,782 | 7,381 |
| Accrued Expenses | 5,426 | 11,030 | 5,999 | 10,093 | 22,005 |
| Other current liabilities | N/A | 39 | 37 | 134 | 797 |
| TOTAL | $11,818 | $31,894 | $12,640 | $17,008 | $31,898 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 15,984 | 15,636 | 18,029 |
| Other Non-Current Liabilities | 1,633 | 3,283 | 4,698 | 5,978 | 7,093 |
| TOTAL | $1,633 | $3,283 | $20,682 | $21,615 | $25,122 |
| Total Liabilities | $13,451 | $35,177 | $33,322 | $38,622 | $57,020 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,232 | 10,493 | 4,171 | 4,171 | 4,160 |
| Common Shares | 1 | N/A | 0 | 0 | 10 |
| Retained earnings | -476,893 | -436,684 | -392,081 | -349,734 | -304,093 |
| Other shareholders' equity | 35 | -1 | -126 | -62 | 0 |
| TOTAL | $142,428 | $-6,905 | $32,990 | $69,108 | $45,275 |
| Total Liabilities And Equity | $155,879 | $28,272 | $66,312 | $107,730 | $102,295 |